Business & Tech
Lexington Pharmaceutical Company Makes Big Purchase
Cubist spent $1.6 billion to acquire two companies.
Lexington’s Cubist Pharmaceuticals Inc. has laid out big bucks to purchase to companies.
The company, known for its antibiotic Cubicin bought Optimer Pharmaceuticals Inc. and Trius Theraputics Inc. for a combined $1.6 billion, according to a story in the Boston Globe.
The company hopes to generate as much as $1 billion annually from the deal.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Cubist gains an experimental drug to treat skin infections being developed by Trius, which the company seeks to launch in 2014, according to a report by Reuters.
By purchasing Optimer, the company gains an antibacterial drug Dificid used to treat infectious diarrhea, Reuters reported.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Read more by clicking here.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here